Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Pediatrics/Neonatology | Vaccines

Clinical Trials: Vaccines


A listing of clinical trials currently looking for volunteers to enroll in Vaccines studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Daphne : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Arizona

Chandler : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Mesa : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tucson : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Arkansas

Jonesboro : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Little Rock : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

California

Paramount : Center for Clinical Trials, LLC

SHINE Study: We're looking for young adults to volunteer a clinical research study exploring new immunization options for meningococcal diseases like meningitis.

View More »

Fresno : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Hayward : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Huntington Beach : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Loma Linda : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Moreno Valley : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Paramount : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Sacramento : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

San Diego : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Valley Village : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Colorado

Denver : Radiant Research - Denver

Meningitis Vaccine Research Study

Longmont : Longmont Medical Research Network

Investigational Combination Vaccine Study for Ages 4 through 6

View More »

Colorado Springs : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Denver : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Connecticut

Norwich : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Florida

Miami : Research Site

Healthy Volunteers of All Ages Needed

Pinellas Park : Radiant Research - St. Petersburg

Clinical Research for Flu Vaccine

Pinellas Park : Radiant Research - St. Petersburg

Flu Vaccine Research Study

Pinellas Park : Radiant Research - St. Petersburg

Flu Vaccine Research Study

Tampa : Tampa Clinical Research

Family trip to Asia? Mosquitoes spread the disease Japanese Encephalitis all over Asia. Your child(or the child of someone you know) may be eligible to participate in a research study being conducted by Passport Health and Tampa Clinical Research.

View More »

Tampa : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Georgia

Atlanta : Radiant Research - Atlanta

Meningitis Vaccine Research Study

View More »

Atlanta : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Dalton : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Marietta : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Woodstock : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Idaho

Meridian : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Illinois

DeKalb : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Iowa

Council Bluffs : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Kansas

Prairie Village : CTT Research

Flu Vaccine Trial

Wichita : Wichita Clinic, PA

Clinical Research Trial studying Rheumatoid Arthritis Therapy and Vaccines

View More »

Augusta : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Wichita : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Kentucky

Lexington : Central Kentucky Research Associates

Melanoma Vaccine

View More »

Bardstown : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Louisville : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Massachusetts

Brockton : Beacon Clinical Research

65+ Flu Vaccine Research Study

Michigan

Stevensville : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Minnesota

Edina : Radiant Research - Minneapolis

Vaccine Research

View More »

Saint Pail : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Saint Paul : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Missouri

St. Louis : Radiant Research - St. Louis

A Clinical Research Study for Meningitis Vaccine (People 56+)

St. Louis : Radiant Research - St. Louis

Clinical Research for Vaccine (Measles, Mumps, Rubella)

St. Louis : Radiant Research - St. Louis

Flu Vaccine Research Study

View More »

Kansas City : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Saint Louis : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

St. Louis : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Nebraska

Fremont : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Lincoln : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Omaha : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Nevada

Henderson : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

New Jersey

Edison : Anderson & Collins Clinical Research, Inc.

Are you at least 65 years old? Are you planning to get a FLU VACCINE this year?

New York

Mineola : Winthrop University Hospital Clinical Trials Center

Pediatric Meningococcal Vaccine

Mineola : Winthrop University Hospital Clinical Trials Center

Preventative vaccine

View More »

East Syracuse : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Syracuse : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

North Carolina

Cary : PMG Research of Cary

Flu Vaccine Coming in October

Cary : PMG Research of Cary

Healthy Volunteers Needed for Vaccine Research Study

Charlotte : PMG Research of Charlotte

Flu Vaccine Coming in October

Charlotte : Piedmont Medical Research

The Flu Stinks, So Protect Yourself!

Charlotte : PMG Research of Charlotte

The Flu Stinks, So Protect Yourself!

Hickory : PMG Research of Hickory

Flu Vaccine Coming in October

Raleigh : PMG Research of Raleigh

Attention: Men and Women age 65 years and older are invited to participate in a Flu Vaccine Research Study.

Raleigh : PMG Research of Raleigh

Flu Vaccine Coming in October

Raleigh : Wake Research Associates Updated

Study of MMR Vaccine for Children

Salisbury : PMG Research of Salisbury

Flu Vaccine Coming in October

Wilmington : PMG Research of Wilmington

Clostridium Difficile Vaccine: Do You Have An Upcoming Surgery Scheduled?

Wilmington : PMG Research of Wilmington

Flu Vaccine Coming in October

Wilmington : PMG Research of Wilmington

Research Volunteers Needed

Winston-Salem : PMG Research of Winston-Salem

Flu Vaccine Coming in October

View More »

Durham : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Raleigh : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

North Dakota

Fargo : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Ohio

Akron : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Cincinnati : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Cleveland : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Columbus : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Huber Heights : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

View More »

Kettering : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Oklahoma

Norman : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Oklahoma City : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tulsa : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Pennsylvania

Rhode Island

Cranston : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Warwick : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

South Carolina

Anderson : Radiant Research - Anderson

Flu Vaccine Research Study

Anderson : Radiant Research - Anderson

Meningitis Vaccine (Pediatric) Research Study

Anderson : Radiant Research - Anderson

What's News @ Radiant Research Anderson

Mt Pleasant : Coastal Carolina Research Center

Flu Vaccine Study - Aged 65 years of age or older? Volunteers needed for an investigational flu vaccine research study.

Mt Pleasant : Coastal Carolina Research Center

Pandemic Bird Flu Vaccine Research Study - Healthy Volunteers aged 18 to 64

View More »

Anderson : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Charleston : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Mount Pleasant : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tennessee

Bristol : PMG Research of Bristol

Attention: Men and Women age 65 years and older are invited to participate in a Flu Vaccine Research Study.

Knoxville : PMG Research of Knoxville

Flu Vaccine Coming in October

Nashville : Clinical Research Associates, Inc.

Adolescent Vaccine Study

Nashville : Clinical Research Associates, Inc.

Flu Vaccine

View More »

Bristol : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Nashville : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Texas

Houston : DM Clinical Research

An investigational vaccine study that would limit the amount of shots given.

Houston : DM Clinical Research

Pediatric Meningitis Vaccine- Houston,TX

Houston : DM Clinical Research

Pediatric RSV Vaccine- Houston,TX

San Antonio : Lung Diagnostics, LTD

Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)

View More »

Austin : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Dallas : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Houston : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

San Antonio : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tomball : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Utah

Bountiful : Pharmaceutical Research Organization

If you have a healthy child 9 months to 15-18 months, we invite you to see if he or she may qualify for a medical research study to determine how the Menactra vaccine interacts with Pentacel.

Murray : Radiant Research - Salt Lake City

Meningitis Research Study

Salt Lake City : J. Lewis Research, Inc.

MMR Vaccine (12-15 months)

Salt Lake City : J. Lewis Research, Inc.

Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes

South Jordan : J. Lewis Research, Inc.

Meningitis Vaccine

South Jordan : Jordan River Family Medicine

MMR Vaccine

South Jordan : J. Lewis Research, Inc.

MMR Vaccine

View More »

Murray : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Salt Lake City : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

South Jordan : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

West Jordan : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Virginia

Charlottesville : Charlottesville Medical Research

Meningococcal vaccine

View More »

Burke : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Charlottesville : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Washington

Vancouver : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Wisconsin

La Crosse : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Monroe : Pfizer Investigational Site

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Canada

Montreal : Pfizer Investigational Site

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

Sherbrooke : Pfizer Investigational Site

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

Toronto : Pfizer Investigational Site

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.